Editorial
doi: 10.1093/annonc/mdh033.
Her2-neu: a target in lung cancer?
- PMID: 14679110
- DOI: 10.1093/annonc/mdh033
Item in Clipboard
Editorial
Her2-neu: a target in lung cancer?
Ann Oncol.
2004 Jan.
Free article
No abstract available
Comment on
-
Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer.Ann Oncol. 2004 Jan;15(1):19-27. doi: 10.1093/annonc/mdh031. Ann Oncol. 2004. PMID: 14679114 Clinical Trial.
Similar articles
-
The role of HER2/neu expression and trastuzumab in non-small cell lung cancer.Semin Oncol. 2004 Feb;31(1 Suppl 1):75-82. doi: 10.1053/j.seminoncol.2003.12.018. Semin Oncol. 2004. PMID: 14981584 Review.
-
HER2/neu intragenic kinase domain mutations may be major determinant of response to trastuzumab or specific kinase inhibitors in non-small cell lung cancer patients.Lung Cancer. 2005 Aug;49(2):279-80. doi: 10.1016/j.lungcan.2005.02.013. Epub 2005 Apr 9. Lung Cancer. 2005. PMID: 16022924 No abstract available.
-
HER2/neu expression in malignant lung tumors.Semin Oncol. 2002 Feb;29(1 Suppl 4):51-8. doi: 10.1053/sonc.2002.31523. Semin Oncol. 2002. PMID: 11894014
-
Trastuzumab in the treatment of non-small cell lung cancer.Semin Oncol. 2002 Feb;29(1 Suppl 4):59-65. doi: 10.1053/sonc.2002.31526. Semin Oncol. 2002. PMID: 11894015 Review.
-
HER2 mutation and response to trastuzumab therapy in non-small-cell lung cancer.N Engl J Med. 2006 Jun 15;354(24):2619-21. doi: 10.1056/NEJMc060020. N Engl J Med. 2006. PMID: 16775247 No abstract available.
Cited by
-
The History and Development of HER2 Inhibitors.Pharmaceuticals (Basel). 2023 Oct 12;16(10):1450. doi: 10.3390/ph16101450. Pharmaceuticals (Basel). 2023. PMID: 37895921 Free PMC article. Review.
-
Epidermal growth factor receptor status and Notch inhibition in non-small cell lung cancer cells.J Biomed Sci. 2015 Oct 24;22:98. doi: 10.1186/s12929-015-0196-1. J Biomed Sci. 2015. PMID: 26497899 Free PMC article.
-
Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer.Invest New Drugs. 2005 Jun;23(3):263-9. doi: 10.1007/s10637-005-6736-x. Invest New Drugs. 2005. PMID: 15868384 Clinical Trial.
-
Expression proteomics study to determine metallodrug targets and optimal drug combinations.Sci Rep. 2017 May 8;7(1):1590. doi: 10.1038/s41598-017-01643-1. Sci Rep. 2017. PMID: 28484215 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
